What are the recommended treatment options for rosacea?

Treatment for Rosacea

Rosacea treatment must be phenotype-directed, targeting specific clinical features (transient/persistent erythema, papules/pustules, telangiectasia, or phyma) with corresponding first-line therapies rather than treating "rosacea" as a single entity. 1

General Skincare Foundation (All Patients)

• SPF 30+ sunscreen, gentle cleansers, moisturizers, and trigger avoidance form the essential baseline for all rosacea patients regardless of phenotype. 1

Phenotype-Specific First-Line Treatment Algorithm

Transient Erythema (Flushing)

• Topical α-adrenergics (brimonidine or oxymetazoline for symptomatic control) 1, 2
• Oral beta-blockers 1
• Pulsed-dye laser (PDL) 1
• Oral doxycycline 1

Note: Evidence quality for flushing treatments is limited to case reports and clinical experience rather than high-quality trials. 1

Persistent Erythema

• Topical brimonidine (vasoconstrictor for symptomatic relief) 1, 2
• Intense pulsed light (IPL) 1
• Oral doxycycline 1

Inflammatory Papules/Pustules (Severity-Based)

Mild:

• Topical azelaic acid 1, 2
• Topical ivermectin 1, 2
• Topical metronidazole 1, 2

Moderate:

• Topical azelaic acid or ivermectin 1
• Oral doxycycline 40 mg (anti-inflammatory dose, noninferior to 100 mg and superior to placebo) 1

Severe:

• Topical ivermectin 1
• Oral doxycycline (low-dose 40 mg is the drug of choice for systemic therapy) 1, 2
• Oral isotretinoin (alternative for therapy-resistant cases) 1, 2

Telangiectasia

• Electrodessication 1
• IPL 1
• Lasers 1

Phyma

Clinically Inflamed ("Active"):

• Oral doxycycline 1

Clinically Noninflamed ("Fibrotic" or "Burnt Out"):

• Physical modalities (electrosurgery, dermabrasion, surgical resurfacing) 1, 3

Combination Therapy Strategy

• Multiple cutaneous features can and should be treated simultaneously with more than one agent. 1
• Moderate and severe presentations require combination treatment including general skincare, physical modalities, and pharmaceutical agents. 1
• If first-line treatment fails, either switch to an alternative first-line option or add an additional first-line agent from the algorithm. 1

Ocular Rosacea Management

• Very mild ocular rosacea not bothering the patient requires only lid hygiene. 1
• Artificial tear substitutes for mild burning/stinging can be prescribed by dermatologists. 1
• Topical antimicrobials achieve complete or partial response in 91% of patients. 4
• Oral antibiotics achieve response in 89% of patients. 4
• Cyclosporine ophthalmic emulsion achieves response in 87% of patients. 4
• Refer to ophthalmology for severity beyond what lid hygiene can control, or for blepharitis, blurred vision, foreign body sensation, interpalpebral bulbar hyperemia, photophobia, or significant tearing. 1

Maintenance Therapy Principles

• Use the minimum treatment necessary to maintain control. 1
• Continue treatments for sufficient duration (treatment-specific) before switching alternatives. 1
• Maintenance approach depends on treatment modality and patient preference for ongoing therapy. 1

Critical Pitfalls to Avoid

• Do not treat rosacea as a single disease entity—identify and target specific phenotypic features individually. 1
• Do not use high-dose doxycycline (100 mg) when low-dose (40 mg) provides equivalent efficacy with better tolerability. 1
• Do not delay referral to ophthalmology for ocular symptoms beyond mild burning/stinging—vision-threatening complications can occur. 1
• Do not prescribe ocular rosacea treatment beyond artificial tears before ophthalmology referral unless specifically trained. 1